Lv4
488 积分 2026-06-05 加入
H3K18 lactylation drives CD8+ T cell exclusion and anti-PD-1 resistance in hepatocellular carcinoma
1天前
已完结
Efficient transplantation of STING protein-enriched endoplasmic reticulum for tumor immunotherapy via ionizable membrane fusion liposome
2天前
已完结
Unphosphorylated tyrosines mediate PD-1 inhibition of T cell signaling condensate formation
24天前
已完结
GG01-40 PHASE 1/2 STUDY OF AN ANTI-PD-L1/IL-15 VARIANT FUSION PROTEIN (SIM0237) IN BCG-UNRESPONSIVE HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)
1个月前
已完结
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial
2个月前
已完结
In vivo characterization of RC28-E, a fusion protein targeting VEGF and bFGF: Pharmacokinetics and ocular distribution in primates
2个月前
已完结
不同批次的重组诱饵型受体创新药物RC28-E1与RC28-E2对视网膜新生血管的药效学比较及机制
2个月前
已完结
Abstract 5542: Novel PD-1xVEGFxIL-2 trispecific immune modulator with superior safety and greater efficacy
2个月前
已完结
Engineering CAR-NK Cells to Overcome Tumor Microenvironment (TME) Barriers in Solid Tumors
3个月前
已完结
605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models
4个月前
已完结